[HTML][HTML] ABCB1 C3435T, G2677T/A and C1236T variants have no effect in eslicarbazepine pharmacokinetics
P Zubiaur, M del Peso-Casado, D Ochoa… - Biomedicine & …, 2021 - Elsevier
Eslicarbazepine acetate is a third-generation anti-epileptic prodrug quickly and extensively
transformed to eslicarbazepine after oral administration. Reduction in seizure frequency in …
transformed to eslicarbazepine after oral administration. Reduction in seizure frequency in …
ABCB1 C3435T, G2677T/A and C1236T variants have no effect in eslicarbazepine pharmacokinetics.
P Zubiaur, D Peso-Casado, D Ochoa… - Biomedicine & …, 2021 - europepmc.org
Eslicarbazepine acetate is a third-generation anti-epileptic prodrug quickly and extensively
transformed to eslicarbazepine after oral administration. Reduction in seizure frequency in …
transformed to eslicarbazepine after oral administration. Reduction in seizure frequency in …
ABCB1 C3435T, G2677T/A and C1236T variants have no effect in eslicarbazepine pharmacokinetics
P Zubiaur, M Del Peso-Casado… - Biomedicine & …, 2021 - pubmed.ncbi.nlm.nih.gov
Eslicarbazepine acetate is a third-generation anti-epileptic prodrug quickly and extensively
transformed to eslicarbazepine after oral administration. Reduction in seizure frequency in …
transformed to eslicarbazepine after oral administration. Reduction in seizure frequency in …
ABCB1 C3435T, G2677T/A and C1236T variants have no effect in eslicarbazepine pharmacokinetics
P Zubiaur, M del Peso-Casado… - Biomedicine and …, 2021 - repositorio.uam.es
Eslicarbazepine acetate is a third-generation anti-epileptic prodrug quickly and extensively
transformed to eslicarbazepine after oral administration. Reduction in seizure frequency in …
transformed to eslicarbazepine after oral administration. Reduction in seizure frequency in …